North America Invasive Neurostimulation Devices Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033
The North America invasive neurostimulation devices market size is expected to reach US$ 5.95 billion by 2033 from US$ 2.96 billion in 2025. The market is estimated to register a CAGR of 9.1% from 2026 to 2033.
Report Coverage
- Product Type: Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, and Other Product Types
- Application: Pain & Sensory Modulation, Functional Disorders, Cognitive & Behavioral Regulation, and Other Applications
- End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Other End Users
US$ 2.96 Bn
Market size in 2025
US$ 5.95 Bn
Market Size by 2033
9.1%
CAGR, 2026 - 2033
2026-2033
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Invasive Neurostimulation Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Invasive Neurostimulation Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Invasive Neurostimulation Devices Market Regional Analysis
6.2 North America Invasive Neurostimulation Devices Market Revenue 2022-2033 (US$ Billion)
6.3 North America Invasive Neurostimulation Devices Market Forecast Analysis
7. North America Invasive Neurostimulation Devices Market Analysis – by Product Type
7.1 Spinal Cord Stimulation Devices
- 7.1.1 Overview
- 7.1.2 Spinal Cord Stimulation Devices: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.2 Deep Brain Stimulation Devices
- 7.2.1 Overview
- 7.2.2 Deep Brain Stimulation Devices: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.3 Sacral Nerve Stimulation Devices
- 7.3.1 Overview
- 7.3.2 Sacral Nerve Stimulation Devices: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.4 Vagus Nerve Stimulation Devices
- 7.4.1 Overview
- 7.4.2 Vagus Nerve Stimulation Devices: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.5 Other Product Types
- 7.5.1 Overview
- 7.5.2 Other Product Types: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8. North America Invasive Neurostimulation Devices Market Analysis – by Application
8.1 Pain & Sensory Modulation
- 8.1.1 Overview
- 8.1.2 Pain & Sensory Modulation: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.2 Functional Disorders
- 8.2.1 Overview
- 8.2.2 Functional Disorders: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.3 Cognitive & Behavioral Regulation
- 8.3.1 Overview
- 8.3.2 Cognitive & Behavioral Regulation: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.4 Other Applications
- 8.4.1 Overview
- 8.4.2 Other Applications: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9. North America Invasive Neurostimulation Devices Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other End Users: North America Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Billion)
10. North America Invasive Neurostimulation Devices Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Invasive Neurostimulation Devices Market Breakdown, by Key Country, 2026 and 2033 (%)
- 10.2.1.1 North America Invasive Neurostimulation Devices Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Billion)
- 10.2.1.1.1 US: North America Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.1.2 US: North America Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.1.3 US: North America Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.2 Canada: North America Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Billion)
- 10.2.1.2.1 Canada: North America Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.2.2 Canada: North America Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.3 Mexico: North America Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Billion)
- 10.2.1.3.1 Mexico: North America Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.3.2 Mexico: North America Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.3.3 Mexico: North America Invasive Neurostimulation Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Medtronic
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Abbott
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston Scientific Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 LivaNova PLC.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Nevro Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 NeuroPace, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Newronika S.p.A.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Saluda Medical Pty Ltd.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Biotronik
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Mainstay Medical
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full North America Invasive Neurostimulation Devices Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.